Autoimmune Diseases

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Immune System Diseases

Narrower: Antiphospholipid Syndrome 1, Immunoglobulin G4-Related Disease 1

Treatments and conditions

Autoimmune Diseases
Treatment and conditionWhere it standsTrials
Belimumab+SOC for antiphospholipid syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for autoimmune diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Efgartigimod alfa for immunoglobulin g4-related diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
fetal MSCs combined with 4SCAR T cells for autoimmune diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.